Quantinno Capital Management LP Has $2.75 Million Stock Position in Acadia Healthcare Company, Inc. $ACHC

Quantinno Capital Management LP lifted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 25.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 117,676 shares of the company’s stock after acquiring an additional 23,913 shares during the quarter. Quantinno Capital Management LP owned approximately 0.13% of Acadia Healthcare worth $2,752,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of ACHC. Goldman Sachs Group Inc. boosted its holdings in shares of Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after acquiring an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. acquired a new position in shares of Acadia Healthcare during the 4th quarter worth approximately $47,960,000. Wellington Management Group LLP increased its stake in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after acquiring an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare in the first quarter worth $43,017,000. Finally, Invenomic Capital Management LP increased its holdings in Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after buying an additional 1,375,647 shares during the period.

Acadia Healthcare Stock Performance

NASDAQ:ACHC opened at $31.53 on Monday. The company has a market capitalization of $2.94 billion, a P/E ratio of -2.53, a P/E/G ratio of 10.23 and a beta of 0.64. The business has a fifty day simple moving average of $29.01 and a two-hundred day simple moving average of $24.50. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. Acadia Healthcare Company, Inc. has a 1 year low of $11.43 and a 1 year high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same period last year, the company earned $0.83 earnings per share. The business’s revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, analysts expect that Acadia Healthcare Company, Inc. will post 1.54 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ACHC. Barclays boosted their price objective on Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research report on Thursday, July 30th. Guggenheim raised their price target on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Royal Bank Of Canada boosted their price objective on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Raymond James Financial upgraded shares of Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price on the stock in a research report on Monday, May 4th. Finally, KeyCorp boosted their target price on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.